BCX4430 – A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease

The adenosine nucleoside analog BCX4430 is a direct-acting antiviral drug under investigation for the treatment of serious and life-threatening infections from highly pathogenic viruses, such as the Ebola virus. Cellular kinases phosphorylate BCX4430 to a triphosphate that mimics ATP; viral RNA poly...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Infect Public Health
Asıl Yazarlar: Taylor, Raymond, Kotian, Pravin, Warren, Travis, Panchal, Rekha, Bavari, Sina, Julander, Justin, Dobo, Sylvia, Rose, Angela, El-Kattan, Yahya, Taubenheim, Brian, Babu, Yarlagadda, Sheridan, William P.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: King Saud Bin Abdulaziz University for Health Sciences. Production and hosting by Elsevier Limited. 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4937725/
https://ncbi.nlm.nih.gov/pubmed/27095300
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jiph.2016.04.002
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller